New Evidence Establishes EPA as Highly Predictive of Skin Graft Failure and Supports the Utility of Systagenix WOUNDCHEK™ Protease Status Point of Care Test in This Application

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

GATWICK, UK--(BUSINESS WIRE)--New evidence presented on Wednesday 15th May 2013 at the European Wound Management Association (EWMA)’s conference in Copenhagen, revealed that elevated protease activity (EPA) was detected in almost half the wounds (43%) that resulted in skin graft failure1.

Help employers find you! Check out all the jobs and post your resume.